INNA-051

Last updated

INNA-051
Vaccine description
Target SARS-CoV-2
Vaccine type Viral vector
Clinical data
Routes of
administration 		Intranasal

INNA-051 is a COVID-19 vaccine candidate developed by Ena Respiratory. [1] [2]

References

  1. ↑ "INNA-051 intranasal safety and tolerability study". anzctr.org.au. 21 April 2021. ACTRN12621000607875p. Retrieved 20 May 2021.
  2. ↑ Clinical trial number NCT05118763 for "Intranasal INNA-051 for Prevention of COVID-19 in Adults" at ClinicalTrials.gov


Syringe with Green Fluid.jpg

This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.